Oncor, Perseus Capital LLC cancer, diagnostics/imaging news

Perseus, an investment firm, withdrew its letter of intent to acquire ONC's Codon Inc. subsidiary, which was conducting research in genetic repair. As a result, Codon will cease operations, and ONC will seek another buyer for Codon.

ONC also reduced its headcount by 30 people to 34 employees. ONC, which will seek cash through the sale of assets and strategic alliances, will maintain manufacturing, selling and internal R&D activities. ONC sells gene-based test systems. ...